Viking Therapeutics, Inc.

LSE:0VQA Stock Report

Market Cap: US$5.9b

Viking Therapeutics, Inc. Company Information

Viking Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Viking Therapeutics, Inc.
  • Ticker: 0VQA
  • Exchange: LSE
  • Founded: 2012
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$5.860b
  • Shares Outstanding: 111.44m
  • Website: https://www.vikingtherapeutics.com

Number of Employees

Location

  • Viking Therapeutics, Inc.
  • 9920 Pacific Heights Boulevard
  • Suite 350
  • San Diego
  • California
  • 92121
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VKTXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDApr 2015
1VTDB (Deutsche Boerse AG)YesCommon StockDEEURApr 2015
0VQALSE (London Stock Exchange)YesCommon StockGBUSDApr 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 10:36
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.